We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01366001
Recruitment Status : Completed
First Posted : June 3, 2011
Last Update Posted : March 9, 2012
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Alkermes, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2012
  Study Completion Date : February 2012